Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter of 2023.
Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results
Categories
Biotechnology
ABBV Earnings: Everything you need to know about AbbVie’s Q4 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The company reported
Eli Lilly and Company all set to report Q4 results. Here’s what to expect
Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully diversified beyond
MRK Earnings: Highlights of Merck’s Q4 2023 financial results
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of 2023, despite
Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report
Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special items, increased
Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net profit, on
Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack A. Elias
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops novel therapies
Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research universities and
Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023. Revenue was
Gilead Sciences reports Q3 earnings. Here’s everything you need to know
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of 2023. Revenues
Gilead Sciences Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET. Listen to
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also
Vertex Pharma Q3 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at 4:00 p.m.
REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third quarter of
AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance
Earnings Summary: Highlights of Centene Corp’s Q3 2023 earnings report
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues and adjusted
Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand the latter’s
Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in the healthcare